Odds ratioc (95 % CI) | p-value | |
---|---|---|
Aboriginal | 0.70 (0.46–1.05) | 0.084 |
Sex | 0.042 | |
Male | 1.00 | |
Female | 1.12 (1.00–1.24) | |
Age at diagnosis (years) | <0.001 | |
18–49 | 1.00 | |
50–59 | 0.89 (0.68–1.15) | |
60–69 | 0.90 (0.70–1.14) | |
70–79 | 0.58 (0.46–0.74) | |
80+ | 0.20 (0.15–0.27) | |
Spread of disease | <0.001 | |
Localised | 1.00 | |
Regional | 0.81 (0.73–0.90) | |
Year of diagnosis | 1.04 (1.02–1.07) | 0.001 |
Place of residence at diagnosis | <0.001 | |
Major cities | 1.00 | |
Inner regional | 0.69 (0.60–0.80) | |
Rurald | 0.66 (0.51–0.83) | |
Comorbiditiese | ||
Chronic pulmonary disease | 1.04 (0.93–1.16) | 0.526 |
Diabetes | 1.08 (0.93–1.25) | 0.300 |
Cardiovascular disease | 0.71 (0.62–0.82) | <0.001 |
Renal disease | 0.74 (0.56–0.97) | 0.029 |
Other comorbidities | 0.60 (0.49–0.72) | <0.001 |
Socioeconomic disadvantage quintile | <0.001 | |
Least disadvantaged | 1.00 | |
Second least disadvantaged | 0.86 (0.73–1.02) | |
Third least disadvantaged | 0.73 (0.61–0.87) | |
Second most disadvantaged | 0.85 (0.72–1.01) | |
Most disadvantaged | 0.63 (0.51–0.76) |